Black Rock Inc. Poseida Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,905,160 shares of PSTX stock, worth $46.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,905,160

Previous 4,950,070 0.91%

Holding current value

$46.6 Million

Previous $15.8 Million 9.29%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$2.0 - $3.46 $89,820 - $155,388	-44,910 Reduced 0.91%	4,905,160 $14.3 Million
Q1 2024 May 10, 2024	SELL	$2.76 - $4.13 $223,844 - $334,955	-81,103 Reduced 1.61%	4,950,070 $15.8 Million
Q4 2023 Feb 13, 2024	SELL	$1.83 - $3.51 $39,904 - $76,539	-21,806 Reduced 0.43%	5,031,173 $16.9 Million
Q3 2023 Nov 13, 2023	SELL	$1.62 - $2.79 $212,683 - $366,287	-131,286 Reduced 2.53%	5,052,979 $12 Million
Q2 2023 Aug 11, 2023	BUY	$1.66 - $3.4 $5.47 Million - $11.2 Million	3,294,442 Added 174.33%	5,184,265 $9.12 Million
Q1 2023 May 12, 2023	BUY	$3.08 - $8.73 $525,906 - $1.49 Million	170,749 Added 9.93%	1,889,823 $5.82 Million
Q4 2022 Feb 13, 2023	BUY	$3.33 - $6.38 $902,949 - $1.73 Million	271,156 Added 18.73%	1,719,074 $9.11 Million
Q3 2022 Nov 14, 2022	BUY	$2.43 - $4.51 $804,779 - $1.49 Million	331,185 Added 29.66%	1,447,918 $5.11 Million
Q2 2022 Aug 12, 2022	SELL	$1.87 - $5.0 $2.53 Million - $6.76 Million	-1,352,221 Reduced 54.77%	1,116,733 $2.88 Million
Q1 2022 May 12, 2022	SELL	$3.22 - $7.04 $270,595 - $591,613	-84,036 Reduced 3.29%	2,468,954 $11.1 Million
Q4 2021 Feb 10, 2022	BUY	$6.23 - $7.6 $123,671 - $150,867	19,851 Added 0.78%	2,552,990 $17.4 Million
Q3 2021 Nov 09, 2021	SELL	$7.09 - $10.71 $61,583 - $93,027	-8,686 Reduced 0.34%	2,533,139 $18.5 Million
Q2 2021 Aug 11, 2021	BUY	$7.96 - $10.07 $20.2 Million - $25.6 Million	2,541,825 New	2,541,825 $25.5 Million

Others Institutions Holding PSTX

# of Institutions

Shares Held

5.44M

Call Options Held

Put Options Held

View Full List

About Poseida Therapeutics, Inc.

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $815M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

More about PSTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account